Thurston Springer Miller Herd & Titak’s First Trust Health Care AlphaDEX Fund FXH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-1,865
Closed -$193K 855
2025
Q2
$193K Buy
1,865
+665
+55% +$66.8K 0.02% 374
2025
Q1
$124K Buy
1,200
+1,148
+2,208% +$123K 0.02% 416
2024
Q4
$5.41K Sell
52
-1,014
-95% -$110K ﹤0.01% 1000
2024
Q3
$119K Sell
1,066
-563
-35% -$61.7K 0.03% 365
2024
Q2
$170K Buy
+1,629
New +$171K 0.05% 329

Other funds holding FXH

Thurston Springer Miller Herd & Titak's FXH Position: Q3 2025 in Review

Thurston Springer Miller Herd & Titak sold out of First Trust Health Care AlphaDEX Fund (FXH) in Q3 2025, closing a stake of 1,865 shares — an estimated $193K sold.

Thurston Springer Miller Herd & Titak first reported a position in FXH in Q2 2024 and held it in 5 quarters. The position peaked at $193K in Q2 2025. 219 funds tracked by Wall St. Rank hold FXH as of Q3 2025.

  • Thurston Springer Miller Herd & Titak reported no remaining First Trust Health Care AlphaDEX Fund position as of Q3 2025 after selling out during the quarter.
  • Thurston Springer Miller Herd & Titak sold 1,865 First Trust Health Care AlphaDEX Fund shares in Q3 2025, an estimated $193K.
  • Thurston Springer Miller Herd & Titak first reported a position in First Trust Health Care AlphaDEX Fund in Q2 2024 and held it in 5 quarters.
  • Thurston Springer Miller Herd & Titak's First Trust Health Care AlphaDEX Fund position peaked at $193K in Q2 2025.
  • 219 funds tracked by Wall St. Rank held First Trust Health Care AlphaDEX Fund as of Q3 2025.

Based on Thurston Springer Miller Herd & Titak's 13F filing for Q3 2025, filed 7 Oct 2025.